Practical grading system for evaluating cisplatin ototoxicity in children.
about
Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale.Platinum-induced hearing loss after treatment for childhood cancerHuman OCT2 variant c.808G>T confers protection effect against cisplatin-induced ototoxicity.Drug-induced ototoxicity: Mechanisms, Pharmacogenetics, and protective strategies.Hearing Loss in Patients Who Received Cranial Radiation Therapy for Childhood CancerCochlear Implantation for Profound Hearing Loss After Multimodal Treatment for Neuroblastoma in Children.Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients.Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastoma.Effect of Sensorineural Hearing Loss on Neurocognitive Functioning in Pediatric Brain Tumor Survivors.Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in children.Examination of risk factors for intellectual and academic outcomes following treatment for pediatric medulloblastomaCommon variants in ACYP2 influence susceptibility to cisplatin-induced hearing lossIncidence of platinum-induced ototoxicity in pediatric patients in Quebec.Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma.Platinum-induced ototoxicity: a review of prevailing ototoxicity criteria.Treatment-induced hearing loss and adult social outcomes in survivors of childhood CNS and non-CNS solid tumors: Results from the St. Jude Lifetime Cohort Study.Yield of screening for long-term complications using the children's oncology group long-term follow-up guidelines.Hearing evaluation of patients with head and neck cancer: Comparison of Common Terminology Criteria for Adverse Events, Brock and Chang adverse event criteria in patients receiving cisplatinThe role of inherited TPMT and COMT genetic variation in cisplatin-induced ototoxicity in children with cancer.Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales--a report from the Children's Oncology Group.Clinically accurate assessment and grading of ototoxicity.Is there a role for carboplatin in the treatment of malignant germ cell tumors? A systematic review of adult and pediatric trials.Ototoxicity (cochleotoxicity) classifications: A review.Ototoxicity and cancer therapy.Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy (ACCL05C1): A Report From the Children's Oncology Group.TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity.Long-term neuropsychological follow-up of young children with medulloblastoma treated with sequential high-dose chemotherapy and irradiation sparing approach.Ototoxicity monitoring in children treated with platinum chemotherapy.Clinical, Pathological, and Molecular Characterization of Infant Medulloblastomas Treated with Sequential High-Dose Chemotherapy.Promoter region variation in NFE2L2 influences susceptibility to ototoxicity in patients exposed to high cumulative doses of cisplatin.Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer.Genetic variation in Otos is associated with cisplatin-induced ototoxicity.Monte Carlo-driven predictions of neurocognitive and hearing impairments following proton and photon radiotherapy for pediatric brain-tumor patients.Ototoxicity: A Challenge in Diagnosis and Treatment.A new grading system for ototoxicity in adults.Early cisplatin induced ototoxicity profile may predict the need for hearing support in children with medulloblastoma."Accelerated ear-age": a new measure of chemotherapy-induced ototoxicity.Hearing Loss in Adult Survivors of Childhood Cancer Treated with Radiotherapy.Incidence of Cisplatin Induced Ototoxicity in Adults with Head and Neck Cancer
P2860
Q24615296-A4DCB32A-016F-4856-B0F1-8F6960EECC22Q26470526-0D537040-D7EA-4A82-8531-5F38EC6E1E11Q27335267-6D78B807-949F-407E-8634-EE4522068D29Q30240026-D2CAA4DA-B0C5-43FB-995A-7281DEE876D0Q30368168-BE1D6F94-4231-488B-9A31-FFA2CD76E258Q30397139-559E32CE-8AB5-4EB1-B322-014EB834BEE6Q30544354-EC8CBC6B-0EE4-4216-A838-1B83610F4B42Q30578179-A1C10C76-E56A-4ED3-90CD-59DFF858E1CAQ30700156-6C7FE91B-4A24-43D1-8B64-E5DF3ADB9E54Q33553382-1491ACE2-D8CC-4DE1-9CED-2A60E9FF29D0Q33894464-35E4D73C-0D42-4AFC-A0FC-7F8D14742B7BQ35172741-AF6DF72C-64A2-4012-B174-18BD4708DBB2Q35197338-244BC398-17D7-4EFA-BEAA-D618442247B3Q35211949-86E6D7AB-BCFF-4A6D-AED2-9CD983677828Q36035287-E342E6F5-42D4-4161-B9A1-299B03F72E77Q36253772-DDEC010A-4B47-4BCA-9C58-EDF30CD2A242Q36449217-8CD22464-7817-45D8-9C86-80B7EFC61851Q36658766-6ADFC1D8-4F07-4C1C-B27C-C560A4F81C7FQ37444522-D49F32AF-9822-4F33-A33D-C88C1B9E61BDQ37570413-B93473EB-08CA-4FD2-98C4-19DE93AE896BQ37959903-E13D7CD4-8051-47CE-BC14-BFD94B09B10AQ38043415-470C4C90-215A-46F1-BE5B-824748EAE6BDQ38653146-B164CA9A-FB93-42EE-A4A3-8345DC7F6768Q38727368-291B1881-EC9B-44E2-B2C2-410C4E5AA384Q38784807-A4C81A00-357D-42DD-88F4-514E94369254Q38818727-C22C1C6B-4D24-45A2-9101-343696C0E51CQ38838969-3239CE87-17B6-4601-9C36-70EBA50A2D8EQ39453840-B83DBE43-E30E-4043-8570-3E09FF637E03Q39795085-E874CC1D-9EA9-44B5-B5BF-46527DD1383DQ40600080-8FC89D47-BDDA-4A4A-8CDE-2AD0F666AC0BQ41069172-C4305793-CED7-46A6-B4C7-849F41EDC990Q41655436-7F1BE62A-4AB2-4504-AB62-F582CF8C9D56Q48146713-FA801504-0691-4E82-A12C-D43EE96E5C81Q50300972-B588998F-541B-4AC8-87DD-EE62BA173152Q50355178-4F57A839-9DB8-4CE6-A960-DFE091468E5FQ50428964-BC07FD18-92D6-4568-B263-546AC69525B5Q50431053-C4E64ECD-713E-48EA-89A3-FC6D189D7EF9Q55546743-68DE1EDE-25BE-4A47-A48D-2AFB5A92058AQ59103194-08148A8F-C919-4689-B65A-A2DD8A1BADC0
P2860
Practical grading system for evaluating cisplatin ototoxicity in children.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Practical grading system for evaluating cisplatin ototoxicity in children.
@en
Practical grading system for evaluating cisplatin ototoxicity in children.
@nl
type
label
Practical grading system for evaluating cisplatin ototoxicity in children.
@en
Practical grading system for evaluating cisplatin ototoxicity in children.
@nl
prefLabel
Practical grading system for evaluating cisplatin ototoxicity in children.
@en
Practical grading system for evaluating cisplatin ototoxicity in children.
@nl
P356
P1476
Practical grading system for evaluating cisplatin ototoxicity in children.
@en
P2093
Nina Chinosornvatana
P304
P356
10.1200/JCO.2009.24.4228
P407
P50
P577
2010-03-01T00:00:00Z